Improvement in renal function in hepatorenal syndrome with N-acetylcysteine
作者： Steve Holt , David Goodier , Richard Marley , David Patch , Andrew Burroughs
DOI: 10.1016/S0140-6736(05)74933-3
关键词: Urology 、 Surgery 、 Renal function 、 Acetylcysteine 、 Kidney disease 、 Chemotherapy 、 Hepatorenal syndrome 、 Medicine
摘要:
elsevier.com
sci-hub.se 参考文章(5)
S P Wilkinson, R Williams, M J Weston, V Parsons, Dialysis in the treatment of renal failure in patients with liver disease. Clinical Nephrology. ,vol. 8, pp. 287- 292 ,(1977)
Murray Epstein, The Kidney in liver disease Hanley & Belfus. ,(1996)
Steve Holt, Richard Marley, Bimbi Fernando, David Harry, Radhi Anand, David Goodier, Kevin Moore, None, Acute cholestasis-induced renal failure: Effects of antioxidants and ligands for the thromboxane A2 receptor Kidney International. ,vol. 55, pp. 271- 277 ,(1999) , 10.1046/J.1523-1755.1999.00252.X
V Arroyo, P Ginès, A L Gerbes, F J Dudley, P Gentilini, G Laffi, T B Reynolds, H Ring-Larsen, J Schölmerich, Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis Hepatology. ,vol. 23, pp. 164- 176 ,(1996) , 10.1002/HEP.510230122
R Keays, P M Harrison, J A Wendon, A Forbes, C Gove, G J Alexander, R Williams, Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. ,vol. 303, pp. 1026- 1029 ,(1991) , 10.1136/BMJ.303.6809.1026